Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
Written by Black Hot Fire Network on February 27, 2023
TOKYO, Feb 27 (Reuters) - Japan's Shionogi & Co Ltd (4507.T) believes its COVID-19 pill will easily garner $2 billion in annual sales if it secures U.S. approval, which the company expects to receive in late 2024, its chief executive said.
